What Peptide Therapy Can Actually Do for the Way Your Skin Is Aging

Somewhere in your forties, the math on skincare changes. The serums you have used for years still smell the same and feel the same on your skin, but they no longer seem to do what they used to do. Fine lines settle in places they did not settle before. The bounce takes longer to come back after a late night. You start to notice that the skin on the back of your hands is telling you something honest, and no amount of retinol is fully answering it.

This is not a personal failure of your routine. It is biology. Skin is the body’s largest organ, and what you see in the mirror is the surface expression of systems much deeper than the dermis. After 40, growth hormone output declines, mitochondrial function in skin cells slows, microcirculation to the dermis weakens, and the body’s internal repair signals quiet down. Topical products work on the outermost layers of the skin. They cannot reach the upstream biology that is actually changing.

That is the gap peptide therapy for skin aging is built to address. Peptides are short chains of amino acids that act as signaling molecules in the body. The right ones, used under physician guidance, can quietly turn certain signals back on, the ones that govern collagen production, tissue repair, cellular energy, and the growth hormone axis. They do not replace good skincare. They work underneath it.

This is a survey of the peptides most relevant to women approaching skin aging from the inside out, organized around the four dimensions of how skin ages and how physicians commonly think about sequencing them into a protocol.

The Four Dimensions of Skin Aging That Peptides Address

Skin aging is not one process. It is at least four, happening in parallel and at different rates depending on your genetics, your hormones, your sleep, your sun history, and a long list of variables you did not choose. Understanding these dimensions is what makes peptide therapy for skin aging make sense, because each peptide tends to address one or two of them well rather than all of them at once.

The first dimension is structural. Collagen and elastin production drop steadily after your mid-thirties. By 50, most women have lost a meaningful percentage of the collagen they had at 30. This is what fine lines, loss of firmness, and changes in skin texture are mostly about.

The second is repair and circulation. The skin is constantly absorbing low-grade damage, from UV exposure, from environmental stress, from inflammation you may not even feel. Younger skin clears that damage efficiently. Older skin clears it more slowly, and the cumulative effect shows up as dullness, uneven tone, and lines that take longer to settle.

The third is cellular. Inside every fibroblast, the cells responsible for producing collagen, mitochondrial function declines with age. Energy production drops. Oxidative stress accumulates. DNA repair becomes less efficient. This is the dimension that anti-aging skincare almost never reaches, because no topical can meaningfully change what is happening inside the cell.

The fourth is hormonal. Growth hormone supports skin thickness, elasticity, and the rate at which fibroblasts produce collagen. After 40, GH output declines significantly, and that decline is part of why skin behaves differently than it did a decade earlier.

Different peptides act on different dimensions. The interesting work is in how a physician combines them.

The Peptides Most Relevant to Skin Aging

GHK-Cu is the peptide most associated with skin in the research literature, and for good reason. It is a copper-binding peptide naturally present in human plasma, and circulating GHK-Cu levels drop sharply with age. Preclinical research indicates that GHK-Cu supports collagen and elastin synthesis, dampens inflammatory signaling, and acts as an antioxidant at the cellular level. In a physician-guided protocol, GHK-Cu is used in injectable form, which allows it to act systemically rather than only on the surface where it is applied.

BPC-157 and TB-500 are commonly thought of as recovery peptides, and for athletes they are. But their relevance to skin aging is real and underdiscussed. Both peptides support tissue repair and angiogenesis, the formation of new microcirculation. Improved blood flow to the dermis matters because the dermis is where collagen is produced and where waste products must be cleared. Preclinical research suggests both peptides also help resolve low-grade chronic inflammation, which is one of the quieter drivers of how skin ages over time.

CJC-1295 and Ipamorelin are usually paired together, and they work on the growth hormone axis. CJC-1295 prompts the pituitary to release more GH, and Ipamorelin amplifies that pulse without disrupting other hormones. The result, supported by early human studies, is restoration of more youthful GH signaling. For skin specifically, this matters because GH supports dermal thickness, fibroblast activity, and the body’s overall rate of tissue renewal.

Epithalon is a different kind of peptide. It works further upstream, on telomere maintenance and the longer arc of cellular aging. The research on Epithalon, much of it from Russian longevity studies, suggests effects on the aging clock at the cellular level. It is not a peptide that changes how your skin looks in two weeks. It is a peptide that may change how your skin ages over years, and women who are thinking about the long view tend to find it interesting for that reason.

NAD+ is technically a coenzyme rather than a peptide, but it is part of the same conversation because it is delivered the same way and addresses the cellular dimension of aging directly. NAD+ levels decline meaningfully with age, and NAD+ is essential for mitochondrial function and DNA repair. Restoring NAD+ to younger levels supports the energy and repair capacity of every cell in the body, including the fibroblasts producing your collagen.

Tesamorelin is worth a brief mention. It is FDA-approved for a specific indication unrelated to skin, but it acts on the growth hormone axis and is sometimes part of a protocol for women who are also working on visceral fat and broader body composition concerns alongside their skin.

How Physicians Sequence These Peptides for Skin Aging

If you read enough about peptides online, you will eventually run into a forum post or a podcast where someone is taking five different peptides simultaneously and reporting wonderful results. That is not how a thoughtful physician designs a protocol, and it is not how the body actually responds best. The signaling systems peptides act on are not designed to be flooded all at once. They respond better to sequence.

Most reported protocols for skin aging in women over 40 follow a logic of repair first, build second, maintain third. The early phase, often four to eight weeks, focuses on tissue repair and lowering the baseline inflammation that interferes with everything downstream. BPC-157 and TB-500 are commonly used together here. The reasoning is straightforward. You do not want to push collagen synthesis hard while the underlying tissue environment is still inflamed or poorly perfused. You want to clear the field first.

The build phase usually overlaps or follows. This is where GHK-Cu and the GH-axis peptides, CJC-1295 and Ipamorelin, do their primary work. GHK-Cu drives collagen and elastin synthesis directly. CJC-1295 with Ipamorelin restores the growth hormone signaling that supports dermal thickness and skin renewal. CJC and Ipamorelin are almost always reported as nightly subcutaneous administration, often with two off-nights per week to preserve the body’s pulsatile signaling pattern. GHK-Cu sequencing varies more across reported protocols. Some physicians run it concurrently with the GH-axis peptides. Others stagger them. There is no single right answer, which is exactly the point at which physician guidance becomes the substantive answer.

The cellular and longevity layer comes later, often after the first two phases are well underway. NAD+ and Epithalon are commonly reported on longer cycles rather than continuous use. Epithalon is typically reported as a 10 to 20 day course, repeated once or twice a year. NAD+ is often reported in loading cycles followed by maintenance. This is slower, deeper work, and it is not meant to be running constantly in the background.

It is worth being honest about something here. Most of what is written online about peptide sequencing is either anecdotal, sourced from biohacker communities, or extrapolated from preclinical research that does not directly translate to a protocol recommendation in humans. There is a real gap between what people are doing and what controlled evidence currently supports. That gap is exactly why physician-guided sequencing exists. A physician designs a sequence around your specific baseline, your goals, your hormone panel, and your tolerance, not around what someone else’s protocol looks like online.

What to Expect from Peptide Therapy for Skin Aging

Peptides are not a face filler. They do not erase a line in a week. What they do, at their best, is shift the underlying biology of how your skin renews itself, and you start to notice the result somewhere between week four and week twelve, depending on the protocol and the individual.

Sleep and energy often shift first, particularly with the GH-axis peptides, because GH signaling affects deep sleep architecture. Then comes recovery quality. Workouts feel different. The bruise on your shin clears faster. Then, gradually, you start to notice your skin. Texture before tone, usually. A certain quality of resilience returns, the kind where your face looks like itself when you wake up rather than needing twenty minutes to settle. Lines do not disappear, but their depth softens, because the skin underneath them is producing more collagen than it was three months earlier.

None of this happens in isolation. Peptide therapy works alongside the things that have always worked, sleep, nutrition, sun protection, a thoughtful topical routine. It is not a replacement for any of those. It is a different layer of the same project.

Why Physician-Guided Peptide Therapy Matters Here

Skin aging is one of the areas where the gap between what is widely available and what is actually appropriate for a given person is largest. The right peptide for you depends on your hormonal baseline, your goals, your other health considerations, and what you are already doing. The right sequence depends on the same. The right dose, the right cycle length, the right combination, none of these is a one-size-fits-all answer, and none of them should be designed by reading a forum.

AIRA is built around physician-guided peptide therapy specifically because that is the only structure in which protocol design and ongoing oversight come together. Every patient is evaluated by a licensed physician. Protocols are designed individually. Peptides are sourced through licensed 503A compounding pharmacies. Adjustments happen as the patient and physician learn together what is working.

If you have been wondering whether peptide therapy fits the kind of skin aging you are actually experiencing, the right next step is a conversation, not a forum search. The AIRA intake quiz takes a few minutes and helps a physician understand your goals before your consultation. From there, the protocol is designed for you, not for someone whose biology and history are not yours.